Evidence map›Paper›PMID 35325096›Full record

ReviewEndocrinology2022

Endocrine-Disrupting Chemicals and Breast Cancer: Disparities in Exposure and Importance of Research Inclusivity.

Ashlie Santaliz Casiano, Annah Lee, Dede Teteh, Zeynep Madak Erdogan, Lindsey Treviño

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. PFAS and their association with the increased risk of cardiovascular disease in postmenopausal women.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  17. Article
  18. Article
  19. Frontiers in public health · 2024
    Article
  20. Hormonal Injustice: Environmental Toxicants as Drivers of Endocrine Health Disparities.Endocrinology and metabolism clinics of North America · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ashlie Santaliz CasianoFood Science and Human Nutrition Department, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA.
Annah LeeDepartment of Population Sciences, Division of Health Equities, City of Hope, Duarte, CA, 91010, USA.
Dede TetehDepartment of Population Sciences, Division of Health Equities, City of Hope, Duarte, CA, 91010, USA.
Zeynep Madak ErdoganFood Science and Human Nutrition Department, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0003-2607-1643
Lindsey TreviñoDepartment of Population Sciences, Division of Health Equities, City of Hope, Duarte, CA, 91010, USA.ORCID 0000-0003-3810-4895
City of Hope · USUniversity of Illinois Urbana-Champaign · USChapman University · US

Funding

NCI NIH HHS L60 CA253971
6 · The paper itself

Abstract

Endocrine-disrupting chemicals (EDCs) are known contributors to breast cancer development. Exposures to EDCs commonly occur through food packaging, cookware, fabrics, and personal care products, as well as external environmental sources. Increasing evidence highlights disparities in EDC exposure across racial/ethnic groups, yet breast cancer research continues to lack the inclusion necessary to positively impact treatment response and overall survival in socially disadvantaged populations. Additionally, the inequity in environmental exposures has yet to be remedied. Exposure to EDCs due to structural racism poses an unequivocal risk to marginalized communities. In this review, we summarize recent epidemiological and molecular studies on 2 lesser-studied EDCs, the per- and polyfluoroalkyl substances (PFAS) and the parabens, the health disparities that exist in EDC exposure between populations, and their association with breast carcinogenesis. We discuss the importance of understanding the relationship between EDC exposure and breast cancer development, particularly to promote efforts to mitigate exposures and improve breast cancer disparities in socially disadvantaged populations.

Indexed as

Breast NeoplasmsEndocrine DisruptorsEnvironmental ExposureFemaleHumansParabensEndocrine DisruptorsParabensbreast cancerendocrine-disrupting chemicalsestrogen receptorstructural racism

Identifiers

PMID35325096
PMCPMC9391683
OpenAlexW4220676072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.